Changes in leptin signaling in patients with NAFLD are related to the pathophysiology of this disease; thus, the association of polymorphisms in the leptin receptor gene with NAFLD has been described [257]. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.